The intestinal FXR signals also promoted NAFLD [122]; the mice treated with antibiotics or tempol showed the increases in the conjugated BA metabolites that inhibited intestinal FXR signaling. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.